US FDA Closes Inspection Of Gland Pharma’s Vizag Sterile API Facility

Gland Pharma Ltd. on Tuesday said it has received an establishment inspection report from the US Food and Drug Administration for its sterile active pharmaceutical ingredients facility at Jawaharlal Nehru Pharma City in Visakhapatnam, indicating closure of the inspection.

The pre-approval inspection was conducted from February 19 to February 25, the company said in a filing to the exchanges.